Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ELVN - Enliven Therapeutics, Inc.
297 K
LAST VALUE
60.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR